Abstract
Background and Aims
Familial Mediterranean fever (FMF) and inflammatory bowel disease (IBD) concordance has been investigated in a few studies. We investigated MEFV mutations and prevalence of FMF disease in Turkish children with IBD and their relationship with the disease severity.
Methods
Sixteen patients with ulcerative colitis (UC), 14 with Crohn’s disease (CD) and three with indeterminate colitis (IC) were enrolled in the study (median age 13 years, range 0.6–16 years, n = 19 boys). Demographic, clinical and laboratory characteristics of the patients were evaluated as well as the parameters of disease severity. All patients were screened for 12 common MEFV mutations.
Results
MEFV mutations were detected in 17 of 66 (25.7%) alleles. Seven patients (four patients with CD, two with IC, and one with UC) were also diagnosed as FMF. FMF disease was found in seven of all IBD patients (21.2%) and four of them had CD. M694V was the leading mutation, and as a disease-causing mutation, it was found to be significantly more frequent in CD patients than UC patients (Fisher’s exact test P = 0.03). Demographics, laboratory evaluations, growth parameters, extraintestinal manifestations, and treatment with immunosuppressive agents other than steroids were comparable between the patients with and without FMF in most aspects.
Conclusions
Although this is a small cohort, disease-causing MEFV mutations and FMF disease rate were increased among our patients with IBD. The increase was prominent among CD patients, whereas in UC the rate was similar to the Turkish healthy control population.
Similar content being viewed by others
References
Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol. 2008;14:413–420.
Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD-2 leucine rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603.
Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606.
Barrett JC, Hansoul S, Nicolae D, et al. Genome-wide association defines more than thirty distinct susceptibility loci for Crohn’s disease. Nat Genet. 2008;40:955–962.
Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum. 1997;40:1879–1885.
Ozen S. Familial Mediterranean fever: revisiting an ancient disease. Eur J Pediatr. 2003;162:449–454.
Ozen S, Aktay N, Lainka E, Duzova A, Bakkaloglu A, Kallinich T. Disease severity in children and adolescents with familial Mediterranean fever: a comparative study to explore environmental effects on a monogenic disease. Ann Rheum Dis. 2009;68:246–248.
Ozen S, Hoffman HM, Frenkerl J, Kastner D. Familial Mediterranean fever (FMF) and beyond: a new horizon. Fourth international congress on the systemic autoinflammatory disease held in Bethesda, USA, 6–10 November 2005. Ann Rheum Dis. 2006;65:961–964.
Turkish FMF study group. Familial Mediterranean fever (FMF) disease in Turkey. Medicine. 2005;84:1–11.
Yilmaz E, Ozen S, Balci B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet. 2001;9:553–555.
Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis. Rheumatology. 2009;48:23–25.
Cattan D, Notarnicola C, Molinari N, Touitou I. Inflammatory bowel disease in non-Ashkenazi Jews with familial Mediterranean fever. Lancet. 2000;355:378–379.
Fidder HH, Chowers Y, Ackerman Z, et al. The familial Mediterranean fever (MEFV) gene as a modifier of Crohn’s disease. Am J Gatroenterol. 2005;100:338–343.
Fidder HH, Chowers Y, Lidar M, Sternberg M, Langevitz P, Livneh A. Crohn's disease in patients with familial Mediterranean fever. Medicine. 2002;81:411–416.
Giaglis S, Mimidis K, Papadopoulos V, et al. Increased frequency of mutations in the gene responsible for familial Mediterranean fever (MEFV) in a cohort of patients with ulcerative colitis: evidence for a potential disease-modifying effect? Dig Dis Sci. 2006;51:687–692.
Ozen S, Bakkaloglu A, Yilmaz E, et al. Mutations in the gene for familial Mediterranean fever: do they predispose to inflammation? J Rheum. 2003;30:2014–2018.
Sari S, Egritas O, Dalgic B. The familial Mediterranean fever (MEFV) gene may be a modifier factor of inflammatory bowel disease in infancy. Eur J Pediatr. 2006;167:391–393.
Yurtcu E, Gokcan H, Yilmaz U, Sahin FI. Detection of MEFV gene mutations in patients with inflammatory bowel disease. Genet Test Mol Biomarkers. 2009;13:87–90.
Ben-Chetrit E, Backenroth R. Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene. Ann Rheum Dis. 2001;60:146–149.
The French FMF. Consortium: a candidate gene for familial Mediterranean fever. Nat Genet. 1997;17:25–31.
The International FMF Consortium. Ancient missense mutations in a new member of RoRet gene family are likely to cause familial Mediterranean fever. Cell. 1997;90:797–807.
Chae JJ, Wood G, Masters SL, et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 modulate IL-1 beta production. Proc Natl Acad Sci USA. 2006;103:9982–9987.
Kalyoncu M, Acar BC, Cakar N, et al. Are carriers for MEFV mutations “healthy”? Clin Exp Rheumatol. 2006;24:120–122.
IBD Working Group of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis—the Porto criteria. J Pediatr Gastroenterol Nutr. 2005;41:1–7.
North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition: Colitis Foundation of America, Bousvaros A, Antonioli DA, Colletti RB, et al. Differentiating ulcerative colitis from Crohn’s disease in children and young adults: report of a working group of the North American society for pediatric gastroenterology, hepatology and the Crohn’s and colitis foundation of America. J Pediatr Gastroenterol Nutr. 2007;44:653–674.
Hyams JS, Ferry GD, Mandel FS, et al. Development and validation of a pediatric Crohn’s disease activity index. J Pediatr Gastroenterol Nutr. 1991;12:439–447.
Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133:423–432.
Yalcinkaya F, Ozcakar ZB, Kasapcopur O, et al. Prevalence of MEFV gene mutations in childhood polyarteris nodosa. J Pediatr. 2007;151:675–678.
Church LD, Cook GP, McDermott MF. Primer: inflammasomes and interleukin 1beta in inflammatory disorders. Nat Clin Pract Rheumatol. 2008;4:34–42.
Gershoni Baruch R, Broza Y, Brik R. Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura. J Pediatr. 2003;143:658–661.
Acknowledgments
Part of this study was presented as a poster at the ESPGHAN 2007 meeting.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Uslu, N., Yüce, A., Demir, H. et al. The Association of Inflammatory Bowel Disease and Mediterranean Fever Gene (MEFV) Mutations in Turkish Children. Dig Dis Sci 55, 3488–3494 (2010). https://doi.org/10.1007/s10620-010-1178-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-010-1178-5